Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,359
Recruiting: 791
Ph III recruiting: 74
Growth YoY: +9.7%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (645)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02081755	Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer	enrolling by invitation	Phase 4	336	Baylor Research InstituteOTHER	1	Jan 27, 2026	clinicaltrials

Data updated 22 days agoSource updated Jan 27, 2026source: clinicaltrials